References
1. Shakoor MT, Birkenbach MP, Lynch M. ANCA-Associated Vasculitis Following Pfizer-BioNTech COVID-19 Vaccine. Am J Kidney Dis. 2021 Oct;78(4):611.
2. Sekar A, Campbell R, Tabbara J, Rastogi P. ANCA glomerulonephritis after the Moderna COVID-19 vaccination. Kidney Int. 2021 Aug;100(2):473.
3. Shimabukuro TT, Cole M, Su JR. Reports of Anaphylaxis After Receipt of mRNA COVID-19 Vaccines in the US—December 14, 2020-January 18, 2021. JAMA. 2021 Mar;325(11):1101–2.
4. Team CC-19 R, Administration F and D. Allergic Reactions Including Anaphylaxis After Receipt of the First Dose of Moderna COVID-19 Vaccine — United States, December 21, 2020–January 10, 2021. Morb Mortal Wkly Rep. 2021 Jan;70(4):125.
5. Lebedev L, Sapojnikov M, Wechsler A, Varadi-Levi R, Zamir D, Tobar A, et al. Minimal Change Disease Following the Pfizer-BioNTech COVID-19 Vaccine. Am J Kidney Dis. 2021 Jul;78(1):142.
6. D’Agati VD, Kudose S, Bomback AS, Adamidis A, Tartini A. Minimal change disease and acute kidney injury following the Pfizer-BioNTech COVID-19 vaccine. Kidney Int. 2021 Aug;100(2):461.
7. E J, K P, P R, G M, I A. Facial Diplegia: A Rare, Atypical Variant of Guillain-Barré Syndrome and Ad26.COV2.S Vaccine. Cureus [Internet]. 2021 Jul 25 [cited 2021 Oct 4];13(7). Available from: https://pubmed.ncbi.nlm.nih.gov/34447646/
8. Van Timmeren MM, Heeringa P, Kallenberg CGM. Infectious triggers for vasculitis. Curr Opin Rheumatol. 2014;26(4):416–23.
9. Jeffs LS, Nitschke J, Tervaert JWC, Peh CA, Hurtado PR. Viral RNA in the influenza vaccine may have contributed to the development of ANCA-associated vasculitis in a patient following immunisation. Clin Rheumatol 2015 354. 2015 Sep;35(4):943–51.
10. Watanabe T. Vasculitis Following Influenza Vaccination: A Review of the Literature. Curr Rheumatol Rev. 2017 May;13(3).
11. Hussein A, Khalil K AL, Bawazir YM. Anti-Neutrophilic Cytoplasmic Antibody (ANCA) Vasculitis Presented as Pulmonary Hemorrhage in a Positive COVID-19 Patient: A Case Report. Cureus. 2020 Aug;12(8).
12. Duran TI, Turkmen E, Dilek M, Sayarlioglu H, Arik N. ANCA-associated vasculitis after COVID-19. Rheumatol Int. 2021 Aug;41(8):1.
13. Zafrir Y, Agmon-Levin N, Shoenfeld Y. Editorial: Post-influenza vaccination vasculitides: A possible new entity. J Clin Rheumatol. 2009 Sep;15(6):269–70.
Figure 1 (a) and 1 (b): Renal biopsy showing necrotizing and crescentic glomerulonephritis with insignificant glomerular immune complex deposit suggesting ANCA associated glomerulonephritis.
Table 1: Laboratory parameters of the patient